mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.02 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
-0.1 |
0.02 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
-0.1 |
0.02 |
mRNA |
MG-132 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.02 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
KIN001-236 |
GDSC1000 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |